| Primary |
| Psychotic Disorder |
14.1% |
| Depression |
10.9% |
| Schizophrenia |
9.4% |
| Schizophrenia, Paranoid Type |
9.4% |
| Product Used For Unknown Indication |
7.8% |
| Schizoaffective Disorder Depressive Type |
7.8% |
| Anxiety |
6.3% |
| Injury |
6.3% |
| Obstruction |
6.3% |
| Schizoaffective Disorder |
4.7% |
| Metabolic Disorder |
3.1% |
| Pain |
3.1% |
| Drug Therapy |
1.6% |
| Epilepsy |
1.6% |
| Ex-tobacco User |
1.6% |
| Hypertension |
1.6% |
| Neurosis |
1.6% |
| Panic Attack |
1.6% |
| Post Concussion Syndrome |
1.6% |
|
| Speech Disorder Developmental |
8.3% |
| Supraventricular Tachycardia |
8.3% |
| Tardive Dyskinesia |
8.3% |
| Weight Increased |
8.3% |
| Asthenia |
4.2% |
| Cognitive Disorder |
4.2% |
| Confusional State |
4.2% |
| Drug Ineffective |
4.2% |
| Epilepsy |
4.2% |
| Foetal Exposure During Pregnancy |
4.2% |
| Insomnia |
4.2% |
| Muscular Weakness |
4.2% |
| Nervous System Disorder |
4.2% |
| Neuroleptic Malignant Syndrome |
4.2% |
| Neurological Examination Abnormal |
4.2% |
| Oesophageal Atresia |
4.2% |
| Rotator Cuff Syndrome |
4.2% |
| Suicidal Ideation |
4.2% |
| Suicide Attempt |
4.2% |
| Transient Ischaemic Attack |
4.2% |
|
| Secondary |
| Schizophrenia |
18.1% |
| Schizophrenia, Paranoid Type |
17.5% |
| Product Used For Unknown Indication |
11.8% |
| Depression |
10.6% |
| Anxiety |
7.6% |
| Psychotic Disorder |
7.3% |
| Drug Use For Unknown Indication |
6.0% |
| Epilepsy |
3.3% |
| Injury |
2.4% |
| Obstruction |
2.4% |
| Foetal Exposure During Pregnancy |
2.1% |
| Bipolar Disorder |
1.8% |
| Hallucination |
1.8% |
| Mental Disorder |
1.5% |
| Pain |
1.2% |
| Adverse Event |
0.9% |
| Asperger's Disorder |
0.9% |
| Blood Cholesterol |
0.9% |
| Dementia |
0.9% |
| Laxative Supportive Care |
0.9% |
|
| Weight Increased |
30.0% |
| Blood Cholesterol Increased |
6.0% |
| Extrapyramidal Disorder |
6.0% |
| Latent Autoimmune Diabetes In Adults |
6.0% |
| Tension |
6.0% |
| Vitamin K Deficiency |
6.0% |
| Maternal Drugs Affecting Foetus |
4.0% |
| Neuroleptic Malignant Syndrome |
4.0% |
| Psychotic Disorder |
4.0% |
| Retinopathy |
4.0% |
| Vitreous Disorder |
4.0% |
| Withdrawal Syndrome |
4.0% |
| Alopecia |
2.0% |
| Asthenia |
2.0% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Drug Abuse |
2.0% |
| Drug Hypersensitivity |
2.0% |
| Drug Ineffective |
2.0% |
| Drug Withdrawal Syndrome Neonatal |
2.0% |
| Foetal Exposure During Pregnancy |
2.0% |
|
| Concomitant |
| Depression |
18.4% |
| Schizophrenia |
17.4% |
| Bipolar Disorder |
16.4% |
| Anxiety |
7.7% |
| Sleep Disorder |
5.7% |
| Major Depression |
4.0% |
| Psychotic Disorder |
4.0% |
| Schizoaffective Disorder |
3.4% |
| Insomnia |
3.1% |
| Pain |
3.0% |
| Hypertension |
2.2% |
| Mental Disorder |
2.0% |
| Schizophrenia, Paranoid Type |
1.9% |
| Agitation |
1.9% |
| Product Used For Unknown Indication |
1.7% |
| Diabetes Mellitus |
1.5% |
| Drug Use For Unknown Indication |
1.4% |
| Hallucination, Auditory |
1.4% |
| Hyperlipidaemia |
1.4% |
| Affective Disorder |
1.3% |
|
| Type 2 Diabetes Mellitus |
33.7% |
| Weight Increased |
13.0% |
| Pancreatitis |
9.7% |
| Tardive Dyskinesia |
9.4% |
| Diabetes Mellitus |
5.8% |
| Tearfulness |
3.3% |
| Type 1 Diabetes Mellitus |
3.3% |
| Death |
2.2% |
| Vomiting |
2.2% |
| Wheelchair User |
2.2% |
| Diabetic Ketoacidosis |
1.7% |
| Obesity |
1.7% |
| Sedation |
1.7% |
| Urinary Tract Infection |
1.7% |
| Uterine Leiomyoma |
1.7% |
| Vision Blurred |
1.7% |
| Diabetic Coma |
1.4% |
| Suicide Attempt |
1.4% |
| Vulvovaginal Candidiasis |
1.4% |
| Diabetic Neuropathy |
1.1% |
|
| Interacting |
| Hallucination |
25.0% |
| Dementia |
12.5% |
| Depression |
12.5% |
| Hepatitis C |
12.5% |
| Hiv Infection |
12.5% |
| Schizoaffective Disorder |
12.5% |
| Extrapyramidal Disorder |
6.3% |
| Schizophrenia |
6.3% |
|
| Extrapyramidal Disorder |
40.0% |
| Priapism |
20.0% |
| Pyrexia |
20.0% |
| Toxicity To Various Agents |
20.0% |
|
